Loading provider…
Loading provider…
Ophthalmology Physician in Houston, TX
NPI: 1306930482Primary Employer
Physicians Referral Service
mdanderson.org
HQ Phone
Get M.D. Bita's Phone Numberphone_androidMobile
Get M.D. Bita's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
FL State Medical License
2021
CA State Medical License
1994 - 2026
OH State Medical License
2024 - 2026
AZ State Medical License
2024 - 2025
GA State Medical License
2024 - 2025
LA State Medical License
2024 - 2025
MS State Medical License
2024 - 2025
OK State Medical License
2020 - 2025
TN State Medical License
2024 - 2025
TX State Medical License
1998 - 2025
WA State Medical License
2024 - 2025
AL State Medical License
2024 - 2024
MI State Medical License
1994 - 2001

American Board of Ophthalmology
Ophthalmology
University of Michigan Health System
Residency • Ophthalmology
1991 - 1994
Advocate Illinois Masonic Medical Center
Internship • Transitional Year
1990 - 1991
Chicago Medical School at Rosalind Franklin University of Medicine and Science
Medical School
Until 1990
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 152 | 204 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 59 | 59 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 47 | 47 |
| 4 | 92285Photography of content of eyes | 28 | 34 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 16 | 17 |
Authors: Oded Sagiv, Neal Akhave, Renata Ferrarotto, Tracy Lu
Journal: Ophthalmic Plast Reconstr Surg
Publication Date: 2025-04-16
Prognostic factors for survival in malignant melanoma of the eyelid skin.
Authors: Eduardo Diaz, Helmuth Goepfert, Ann Gillenwater, Michael Deavers
Journal: Ophthalmic Plast Reconstr Surg
Periorbital oedema and epiphora as ocular side effects of imatinib mesylate (Gleevec).
Authors: Hagop Kantarjian, Todd Shepler
Journal: Eye (Lond)
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Sentinel Lymph Node Biopsy, DRUG: Technetium Tc-99m Sulfur Colloid, PROCEDURE: Lymph Node Mapping
Lead Sponsor: M.D. Anderson Cancer Center
Intervention / Treatment: BEHAVIORAL: Questionnaire, BEHAVIORAL: Audio-Taped Interview
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: Biogen
Intervention / Treatment: DRUG: Rituximab, DRUG: Zevalin